UnitedHealth (UNH) Stock: Buy, Sell, or Hold? | 2 Minute Analysis

Key Concepts

• United Health Group Incorporated (UNH)
• Seeking Alpha Quant Rating System
• Seeking Alpha Analyst Ratings
• Wall Street Analyst Ratings
• Valuation Grade
• PEG Ratio
• Price to Sales (TTM)
• Enterprise Value to Sales (TTM)
• Growth Grade
• EPS Diluted Growth (Forward-Looking)
• Profitability Grade
• Net Income Margin
• Momentum Grade
• One-Year Price Performance
• Three-Month Price Performance
• Revisions Grade
• Earnings Per Share (EPS) Revisions
• Revenue Revisions

United Health Group (UNH) Analysis

This analysis provides a detailed breakdown of United Health Group Incorporated (UNH) based on Seeking Alpha's Quant rating system, analyst ratings, and specific financial metrics.

Quant Rating System and Analyst Consensus

• Quant Rating: UNH currently holds a "Hold" rating from the Seeking Alpha Quant system.
• Seeking Alpha Analysts: In aggregate, 17 Seeking Alpha analysts have issued a "Buy" rating for UNH within the last 30 days.
• Wall Street Analysts: A broader consensus from 27 Wall Street analysts covering UNH over the past 90 days also indicates a "Buy" rating.

Valuation Metrics

The valuation grade for UNH is a "B-".

• PEG Ratio: The Price/Earnings to Growth (PEG) ratio is 69, which is in line with the sector average of 69. This metric suggests that the stock's price is justified by its earnings growth.
• Price to Sales (TTM): The trailing twelve months (TTM) Price to Sales ratio is 69. This is significantly higher than the sector average of 3.70.
• Enterprise Value to Sales (TTM): Similarly, the TTM Enterprise Value to Sales ratio stands at 83, compared to the sector average of 3.84.

Observation: While the PEG ratio is in line with the sector, the higher Price to Sales and Enterprise Value to Sales ratios, when compared to the sector, might suggest the stock could be overvalued based on these specific metrics. However, the transcript notes that the PEG ratio is a key factor to consider in conjunction with growth.

Growth Metrics

The growth grade for UNH is an "F", indicating a significant concern for investors.

• EPS Diluted Growth (Forward-Looking): The forward-looking diluted Earnings Per Share (EPS) growth is projected to be negative 11.03%. This contrasts sharply with the sector average, which is positive at 8.45%.
• Under Pressure: The transcript highlights that the company has been under pressure for a considerable period, likely contributing to this negative growth outlook.

Profitability Metrics

UNH demonstrates strong profitability, earning an "A+" grade.

• Net Income Margin: The net income margin is reported at 4.04%. This is a positive figure, especially when compared to the sector, which is down by approximately half a percent.

Momentum Metrics

The momentum grade for UNH is a "C-".

• One-Year Price Performance: The stock's performance over the last year has been poor, with a decline of 40.69%.
• Three-Month Price Performance: However, there has been a notable recovery in the last three months, with the stock gaining 37.29%. This suggests a potential stabilization in price action.

Revisions Metrics

The revisions grade for UNH is a "C".

• EPS Revisions (Last 3 Months): Over the past three months, there have been an equal number of upward and downward revisions for EPS, with 12 up revisions and 12 down revisions.
• Revenue Revisions (Last 3 Months): For revenue numbers over the same three-month period, there have been seven upward revisions and 12 downward revisions.

Conclusion and Takeaways

United Health Group (UNH) presents a mixed financial picture. While the stock is viewed positively by both Seeking Alpha and Wall Street analysts, with "Buy" ratings from a significant number of coverage, the Seeking Alpha Quant system currently rates it as a "Hold."

The company's valuation metrics show a discrepancy: the PEG ratio is in line with the sector, suggesting fair pricing relative to growth, but the Price to Sales and Enterprise Value to Sales ratios are considerably higher than the sector average, potentially indicating overvaluation on those fronts.

A major concern highlighted is the negative forward-looking EPS growth (-11.03%), which is a significant drag on the "F" growth grade and suggests the company has been facing headwinds.

On the positive side, UNH exhibits strong profitability with an "A+" grade and a healthy net income margin of 4.04%.

Momentum has been weak over the past year (-40.69%), but recent performance shows a significant rebound in the last three months (+37.29%), hinting at potential stabilization.

Revisions for both EPS and revenue are mixed, with an equal number of up and down EPS revisions and more downward than upward revenue revisions in the last three months, contributing to a "C" grade in this category.

Overall, investors should carefully weigh the strong analyst consensus and profitability against the concerning growth outlook and potentially stretched valuation metrics.

Disclaimer: The content presented is for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results. Seeking Alpha is not a licensed securities dealer, broker, or US investment adviser. Investors are solely responsible for their investment decisions.